Comparison of the efficacy of Nebulized 3% hypertonic saline solution and 0.9% normal saline in2-24 m/o children with acute bronchiolitis.

Vice Chancellor of Research, Bushehr University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•a total of infant (2 month to 24 month of age )with mild to moderate bronchiolitis seen in aliasghar tertiary care pediatric center ED in 2008-2010(fall & winter)were randomized to double blind treatment with nebulized salbutamol in either 3% saline or 0.9% saline.
•bronchiolitis: first or second episodes of respiratory distress with wheezing or sign of viral respiratory tract infections includes RR>60; 38c=T; PR>180 or coryza.
•Exclusion criteria: pre-exiting cardiac or pulmonary disease; previous diagnosis of asthma or positive familial history of asthma; previous history of prematurity(GA<34w) or using ventilator at birth; severe illness that needed to immedietly hydration or decrease level of consciousness or letargia or respiratory failure & infants with RR>60; 38c=T; PR>180 second or more episodes of respiratoye distress.

发起方

Vice Chancellor of Research, Bushehr University of Medical Sciences